The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
7,000 - 8,000 jobs Number of planned job losses
Announcement Date
4 November 2009
Employment effect (start)
Foreseen end date
Description
On November 4, pharmaceutical company Johnson & Johnson announced a global restructuring plan that involves 7,000-8,000 job cuts worldwide. The plan is intended to strengthen the company's position and increase its operational efficiency. The company estimates that layoffs will affect six to seven percent of its global workforce, mostly managerial staff. Johnson & Johnson employees approximately 117,000 people at more than 250 manufacturing units in 57 countries. As of November 2009, there is no precise information about when and where the dismissals will occur.
Sources
4 November 2009: Hospodárske noviny
Citation
Eurofound (2009), Johnson & Johnson, Internal restructuring in World, factsheet number 69780, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69780.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
